Fischer Medical Ventures Ltd — Important, 13-11-2025: Company Update

Fischer Medical Ventures reported strong financial results for the quarter and half-year. Revenues for Q2 FY26 grew 118% year-on-year to INR 86 Cr, with half-year revenues at INR 110 Cr, up 120%. EBITDA significantly improved to INR 19 Cr for Q2 (21% margin) and INR 30.5 Cr for the half-year (25% margin), reflecting strong profitability. PAT for Q2 was INR 14 Cr, and INR 19 Cr for H1. The company highlighted its pioneering role in indigenous MRI systems and expansion into CT and interop MRIs. Growth is driven by both Diagnostic and Preventive Health segments, with increasing international focus. The company also completed a stock split.